Overseas commercialization of filgrastim biosimilars

A theme aimed at global commercialization by expanding filgrastim biosimilar products already launched in Japan into overseas markets, including Europe, the United States and Asia.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2016 →Still being written about.

Directionhelps1 helps · 0 hurts · 0 flat

Loading